Cutaneous and mammary apocrine carcinomas have different immunoprofiles

Human Pathology

Volumn 45, Issue 2, 2014, Pages 320-326

  Piris, Adriano ^a,b   Peng, Yan ^c   Boussahmain, Chakib ^a   Essary, Lydia R ^c   Gudewicz, Thomas M ^a,b   Hoang, Mai P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adipophilin; Androgen receptor; Cytokeratin 5 6; Estrogen receptor; GATA3; HER2 neu; Mammaglobin; p63; Progesterone receptor

Indexed keywords

ADIPOPHILIN; ANDROGEN RECEPTOR; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MAMMAGLOBIN; PROGESTERONE RECEPTOR; PROTEIN P63; TRANSCRIPTION FACTOR GATA 3;

ADULT; AGED; APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS APOCRINE CARCINOMA; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY APOCRINE CARCINOMA; METASTASIS; MIDDLE AGED; PRIMARY TUMOR; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SKIN CARCINOMA; VERY ELDERLY;

ADIPOPHILIN; ANDROGEN RECEPTOR; CYTOKERATIN 5/6; ESTROGEN RECEPTOR; GATA3; HER2/NEU; MAMMAGLOBIN; P63; PROGESTERONE RECEPTOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATIN-6; MALE; MAMMAGLOBIN A; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892783366     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.09.007     Document Type: Article

References (29)

1. J.E. Celis, T. Cabezon, and J.M.A. Moreira et al. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort Mol Oncol 3 2009 220 237
2. W.J. Frable, and S. Kay Carcinoma of the breast. Histologic and clinical features of apocrine tumors Cancer 21 1968 756 763
3. H. Japaze, J. Imina, and C. Diaz et al. 'Pure' invasive apocrine carcinoma of the breast: a new clinicopathological entity? Breast 14 2005 3 10
4. S. Dellapasqua, P. Maisonneuve, and G. Viale et al. Immunohistochemically defined subtypes and outcome of apocrine breast cancer Clin Breast Cancer 13 2013 95 102
5. Z. Gatalica Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progresterone receptors in apocrine metaplasia and apocrine carcinoma in situ Pathol Res Pract 193 1997 753 758
6. L.A. Niemeier, D.J. Dabbs, S. Beriwal, J.M. Striebel, and R. Bhargava Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Mod Pathol 23 2010 205 212
7. K.L. Hollowell, S.C. Agle, E.E. Zervos, and T.L. Fitzgerald Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm J Surg Oncol 105 2012 415 419
8. A. Robson, A.J. Lazar, and J. Ben Nagi et al. Primary cutaneous apocrine carcinoma: a clinicopathologic analysis of 24 cases Am J Surg Pathol 32 2008 682 690
9. L.P. Le, D. Dias-Santagata, and A.C. Pawlak et al. Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses PLoS One 7 2012 e47290
10. M. Rollins-Raval, M. Chivukula, G.C. Tseng, D. Jukic, and D.J. Dabbs An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature Arch Pathol Lab Med 135 2011 975 983
11. M. Mahalingam, L.P. Nguyen, J.E. Richards, A. Muzikansky, and M.P. Hoang The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin Mod Pathol 23 2010 713 719
12. A. Fernandez-Flores Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma Cesk Patol 45 2009 108 112
13. A.C. Wolff, M.E. Hammond, and J.N. Schwartz et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
14. S. Vranic, O. Tawfik, and J. Palazzo et al. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast Mod Pathol 23 2010 644 653
15. C. Boussahmain, M.C. Mochel, and M.P. Hoang Perilipin and adipophilin expression in sebaceous carcinomas and mimics Hum Pathol 44 2013 1811 1816
16. D.A. Ostler, V.G. Prieto, J.A. Reed, M.T. Deavers, A.J. Lazar, and D. Ivan Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases Mod Pathol 23 2010 567 573
17. D.L. Brasaemle The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis J Lipid Res 48 2007 2547 2559
18. S. Moritani, S. Ichihara, and M. Haseqawa et al. Intracytoplasmic lipid accumulation in apocrine carcinoma of the breast evaluated with adipophilin immunoreactivity: a possible link between apocrine carcinoma and lipid-rich carcinoma Am J Surg Pathol 35 2011 861 867
19. B.M. Chong, P. Reigan, K.D. Mayle-Combs, D.J. Orlicky, and J.L. McManaman Determinants of adipophilin's function in milk lipid formation of secretion Trends Endocrinol Metab 22 2011 211 217
20. M. Wick, D.M. Ockner, S.E. Mills, J.H. Ritter, and P.E. Swanson Homologous carcinomas of the breasts, skin and salivary glands: a histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma and salivary duct carcinoma Am J Clin Pathol 109 1998 75 84
21. J.W. Nash, T.L. Barrett, and M. Kies et al. Metastatic hidradenocarcinoma with demonstration of Her2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications J Cutan Pathol 34 2007 49 54
22. R.M. Nazarian, P. Kapur, and D. Rakheja et al. Atypical and malignant hidradenomas: a histological and immunohistochemical study Mod Pathol 22 2009 600 610
23. Z. Varga, J. Zhao, and C. Ohlschlegel et al. Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer Histopathology 44 2004 332 338
24. H.S. Qureshi, A.H. Ormsby, M.W. Lee, R.J. Zarbo, and C.K. Ma The diagnostic utility of p63, CK5/6, CK7, and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas J Cutan Pathol 31 2004 145 152
25. R. Bhargava, S. Beriwal, J.M. Striebel, and D.J. Dabbs Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR Appl Immunohistochem Mol Morphol 18 2010 113 118
26. S.J. Plumb, Z.B. Argenyi, M.S. Stone, and B.R. De Young Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma Am J Dermatopathol 26 2004 447 451
27. D. Ivan, A.H. Diwan, and V.G. Prieto Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to skin Mod Pathol 18 2005 137 142
28. E. Sasaki, N. Tsunoda, Y. Hatanaka, N. Mori, H. Iwata, and Y. Yatabe Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers Mod Pathol 20 2007 208 214
29. H. Liu, J. Shi, M.L. Wilkerson, and F. Lin Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas Am J Clin Pathol 138 2012 57 64